Aquestive Therapeutics, Inc. (AQST)
5.375
+0.14
(+2.58%)
USD |
NASDAQ |
Sep 02, 16:00
5.29
-0.08
(-1.58%)
After-Hours: 19:41
Aquestive Therapeutics Cash from Operations (Annual) : -52.43M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -52.43M |
| December 31, 2024 | -35.76M |
| December 31, 2023 | -6.38M |
| December 31, 2022 | -9.789M |
| December 31, 2021 | -32.98M |
| Date | Value |
|---|---|
| December 31, 2020 | -45.46M |
| December 31, 2019 | -60.21M |
| December 31, 2018 | -17.76M |
| December 31, 2017 | 5.824M |
| December 31, 2016 | -8.175M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| LENZ Therapeutics, Inc. | -69.17M |
| ANI Pharmaceuticals, Inc. | 185.22M |
| Corcept Therapeutics, Inc. | 142.00M |
| Veru, Inc. | -30.04M |
| Johnson & Johnson | 24.53B |